7 views
# N Cardiovascular Diseases # **Tags:** * 1 Cardiovascular Disorders * Cardiovascular and oncological diseases * Cardiovascular Disease Risk 3 :::warning Cardio Balance treats digestive issues by promoting the absorption of nutrients, and it helps in the elimination of toxic wastes. So, you’re unlikely to experience stomach ache as a side effect. ::: [![](https://cardio-balance-ph.store-best.net/img/1.jpg)](https://cardio-balance-ph.store-best.net) <div style="height:500px;"></div> ## 1 Cardiovascular Disorders ## <div class="alert alert-info" role="alert"> Ang presyon ng dugo ay isa sa mga pangunahing indikasyon ng kalusugan, na hindi lamang sumasalamin sa puso at sistema ng sirkulasyon, kundi pati na rin sa aktibidad ng mga bato, mga organo ng endokrin, paggawa ng dugo, at ng sistema ng nerbiyos. Kaya naman, walang isang unibersal na gamot laban sa mataas na presyon ng dugo. Hindi ka basta basta puwedeng pumunta sa botika at magtanong ng 'tableta para sa presyon,' kasi agad na tatanungin ng parmasyutiko – anong gamot ang nireseta sa iyo ng doktor? </div> I am happy to offer a scientific Text in English on the subject of alimony and cardiovascular diseases. Alimony and their impact on cardiovascular disease: An Overview Introduction Cardiovascular diseases (CVD) are the leading causes of death. According to the world health organization (WHO), cases a year, billions of deaths, with significant shares are on präventierbare risk factors. One of these key factors is diet. The present work studied the diseases of the connection between certain foods and the risk for cardiovascular disease. Risk factors and diet An unhealthy diet, characterized by a high consumption of saturated fatty acids, TRANS-fats, salt and added sugars continued, stands in close relationship to the development of CVD. The following nutrients and food play a Central role: Saturated and TRANS fats. The excessive consumption of foods like fatty meat, full fat dairy products and processed Snacks leads to an increase in LDL‑cholesterol (bad cholesterol) and increases the risk for atherosclerosis and coronary heart disease. Salt (Sodium). A high salt volume is associated with high blood pressure (hypertension), a major risk factor for stroke and heart attack. Many ready meals and Snacks contain excessive amounts of hidden salt. Sugar. An increased consumption of sugary drinks and sweets promotes Obesity, type 2 Diabetes mellitus and dyslipidemia are all risk factors for CVD. Refinierte Carbs. Foods with a high glycemic Index (e.g., white bread, rice) can contribute to insulin resistance and inflammatory processes in the body. Protective Foods At the same time, there is food, their regular consumption is associated with a lower risk of CVD: Fruits and vegetables. Rich in fiber, vitamins and antioxidants that lower the risk of high blood pressure, and inflammatory processes. Studies show that a daily consumption of at least 5 portions a positive impact. Nuts and seeds. Sources of unsaturated fatty acids and fiber; they contribute to the reduction of LDL‑cholesterol. Fatty fish (e.g. salmon, mackerel). Omega‑3 fatty acids, the anti-supply‑can have flammable and heart rhythm disorders prevention. Whole-grain products. To reduce the risk of heart attacks due to their fiber and nutrient density. Olive oil. A major component of the Mediterranean diet, rich in mono-unsaturated fats and polyphenols. Recommendations and conclusion On the Basis of the current evidence, the following nutritional recommendations for the prevention of cardiovascular diseases can be derived: Reduction in the consumption of saturated and TRANS fats. Limiting the daily intake of salt to less than 5 g. Avoid sugary soft drinks. Increased consumption of fruits, vegetables, nuts, fatty fish and whole grain products. Priority use of vegetable Oils (e.g., olive oil) instead of animal fats. A balanced, nutritious diet is an essential part of the prevention of cardiovascular diseases. Through targeted dietary changes, the individual risk can be significantly reduced, and the quality of life and increase life expectancy. Further long-term studies are needed to investigate the exact mechanisms of action and optimal diet forms. If you want, I can make certain sections in more detail or additional sources and add data! > A sedentary lifestyle, alcohol, and cigarette consumption increase body weight which in turn hinders healthy blood circulation and strength of arteries and veins. This results in high blood pressure. So, if you’re overweight, you need to monitor your blood pressure frequently. ![](https://cardio-balance-ph.store-best.net/img/6.jpg) <a href="https://hedgedoc.ctf.mcgill.ca/s/koWc4a0b6">https://hedgedoc.ctf.mcgill.ca/s/koWc4a0b6</a> Cardio Balance is formulated and made after years of rigorous research and clinical study of the ingredients. The unique combination of each ingredient brings out optimal effectiveness in supporting heart and blood pressure. <a href="https://pads.cantorgymnasium.de/s/BaMF42gZh">Presyong pang-promosyon</a> ## Cardiovascular and oncological diseases ## Cardiovascular diseases for Oncology patients: interactions and clinical challenges The treatment of oncological diseases has made in the last few decades, significant progress, which has led to an increased survival rate of cancer patients. At the same time, an important Problem is in the foreground: the incidence of cardiovascular diseases (HKK) in this group of patients is increasing. This development is due to both the increase in life expectancy after cancer treatment, as well as to the cardiotoxic effects of many therapies. Cardiac toxicity of oncological therapy procedures Many of the standard therapies for cancer, especially chemotherapy and radiation therapy, can exert adverse effects on the heart and the vascular system. Among the most commonly responsible substances Anthracyclines (e.g., Doxorubicin), tyrosine kinase inhibitors and immune therapies. Anthracyclines can lead to a Doxorubicin-induced cardiomyopathy, which is characterized by a reduction in the left ventricular ejection performance. Radiation therapy in the Thoracic region, in turn, increases the risk for pericarditis, coronary artery disease, and Valvular. Risk factors and common Pathomechanisms A number of factors increases the risk for the development of HKK in Oncology patients: pre-existing cardiovascular disease prior to the start of cancer treatment; higher age; metabolic disorders (Diabetes mellitus, hyperlipidemia); Style factors (Smoking life, lack of physical activity). In addition, recent studies show that oncogenic signaling pathways and inflammatory processes in tumor development as well as in the development of atherosclerosis play a role. This common biological mechanisms may increase the risk for cardiovascular complications in cancer patients. Diagnostics and Monitoring Early detection of cardiac damage is crucial for the prevention of severe complications. Among the most important diagnostic procedures: Echocardiography for evaluation of cardiac function; The determination of biomarkers, such as Troponin and N‑terminal pro-B-type Natriuretic peptide (NT-proBNP); cardiac resonance imaging (MRI) magnet for a detailed assessment of myocardial changes. Regular Monitoring during and after the completion of the Oncology therapy, allows for the timely Intervention can prevent the progression of cardiac dysfunction. Therapeutic strategies and multidisciplinary care The treatment of cardiovascular complications in cancer patients requires an individualized approach. In many cases, cardio‑used-protective drugs (e.g. ACE-inhibitors, beta-blockers), in order to stabilize the function of the heart. A special focus is on the close cooperation between cardiologists and oncologists — a concept that is referred to as cardio-Oncology. This multi-disciplinary care allows you to: Consideration of the Benefit‑risk ratio in the selection of therapies; early identification of patients with high cardiovascular risk; Development of individual prevention and treatment strategies. Summary and Outlook Cardiovascular disease in patients with oncological diseases is a growing challenge. The implementation of preventive measures, regular Monitoring, and multidisciplinary care can improve quality of life and improve survival duration of these patients significantly. Future research should focus on the development of new cardio‑ protective strategies, as well as on the optimization of Screening and monitoring protocols. <a href="https://pad.gusted.xyz/s/HgsxMgTiJ">Cardiovascular Disease Risk 3</a> ** N Cardiovascular Diseases **. Heart healthy life full of energy! You worry about your heart and circulatory system? Cardiovascular diseases are among the most common health problems of our time — but Prevention can make a big difference! Our modern prevention program helps you to keep your heart healthy and to detect risks at an early stage. What we offer you: comprehensive advice by experienced cardiologists; individual risk analysis: blood pressure, cholesterol, blood sugar, and more; personalized recommendations for lifestyle modification (diet, exercise); modern diagnostics with gentle methods of investigation; accompanied by training programmes for the strengthening of the cardiovascular system. Early detection saves lives. You can provide free advice and you will get a first Overview of your heart health profile. 👉 Appointment book online now or call us on: +49 XXX XXXXXXX Your heart deserves the best care you invest in your future! - [x] <a href="https://pad.ccc-p.org/s/tSd-z_OE-A">1 Cardiovascular Disorders</a> - [x] <a href="https://md.gafert.org/s/Mp7b5wkvq">Cardiovascular and oncological diseases</a> - [x] <a href="https://notas.gaiacoop.tech/s/9yrUp40bh">Cardiovascular Disease Risk 3</a> - [x] <a href="https://md.micronited.de/s/Hki67Ug7zl">https://md.micronited.de/s/Hki67Ug7zl</a> <a href="https://n.jo-so.de/s/oLONuxgtB">https://n.jo-so.de/s/oLONuxgtB</a> <a href="https://hedgedoc.jcg.re/s/xhFpGQrVl0">https://hedgedoc.jcg.re/s/xhFpGQrVl0</a> <a href="https://www.notizen.kita.bayern/s/3SUlwiSfA4">https://www.notizen.kita.bayern/s/3SUlwiSfA4</a> <a href="https://hedgedoc.team23.org/s/VQhb1s140c">https://hedgedoc.team23.org/s/VQhb1s140c</a> <a href="https://pad.medialepfade.net/s/L2jQvIcDK">https://pad.medialepfade.net/s/L2jQvIcDK</a> <a href="https://pads.tobast.fr/s/pmExHLSwhg">https://pads.tobast.fr/s/pmExHLSwhg</a> <a href="https://om-office.de/s/SJuoutg7Mx">https://om-office.de/s/SJuoutg7Mx</a> <a href="https://pad.mytga.de/s/Stx6bU4rx">https://pad.mytga.de/s/Stx6bU4rx</a> <a href="https://docs.localcharts.org/s/XE4KmItuD">https://docs.localcharts.org/s/XE4KmItuD</a> <a href="https://doc.interscalar.eu/s/hMe-pOpqT">https://doc.interscalar.eu/s/hMe-pOpqT</a> <a href="https://md.interhacker.space/s/KbV7Xx-s8">https://md.interhacker.space/s/KbV7Xx-s8</a> <a href="https://md.globenet.org/s/sSwjlYn0j">https://md.globenet.org/s/sSwjlYn0j</a> <a href="https://doc.projectsegfau.lt/s/JDwScbwbyd">https://doc.projectsegfau.lt/s/JDwScbwbyd</a> <a href="https://pad.fablab-siegen.de/s/g8vxek2kT1">https://pad.fablab-siegen.de/s/g8vxek2kT1</a> <a href="https://pad.nantes.cloud/s/y0_Mv6aK9Z">https://pad.nantes.cloud/s/y0_Mv6aK9Z</a> <a href="https://pad.gusted.xyz/s/iumQ9zQYC">https://pad.gusted.xyz/s/iumQ9zQYC</a> <a href="https://hedgedoc.et.aksw.org/s/JM9icK76s">https://hedgedoc.et.aksw.org/s/JM9icK76s</a> <a href="https://pad.aleph.world/s/Og9YBN7gb">https://pad.aleph.world/s/Og9YBN7gb</a> <a href="https://hdoc.csirt-tooling.org/s/D3VAH2b1gu">https://hdoc.csirt-tooling.org/s/D3VAH2b1gu</a> <a href="https://docs.snowdrift.coop/s/LZUSVivRC">https://docs.snowdrift.coop/s/LZUSVivRC</a> <a href="https://hedgedoc.obco.pro/s/0o54OmwBe">https://hedgedoc.obco.pro/s/0o54OmwBe</a> <a href="https://pad.mytga.de/s/AKZtaSbqx">https://pad.mytga.de/s/AKZtaSbqx</a> <a href="https://codi.sevenvm.de/s/f-uGRZzdz">https://codi.sevenvm.de/s/f-uGRZzdz</a> <a href="https://pad.koeln.ccc.de/s/Nh9ISUAxx">https://pad.koeln.ccc.de/s/Nh9ISUAxx</a> <a href="https://md.coredump.ch/s/svIBu9V4s">https://md.coredump.ch/s/svIBu9V4s</a> <a href="https://pad.sra.uni-hannover.de/s/dcAX8kgn0L">https://pad.sra.uni-hannover.de/s/dcAX8kgn0L</a> <a href="https://md.sebastians.dev/s/faxDiYH3P">https://md.sebastians.dev/s/faxDiYH3P</a> <a href="https://notes.llgoewer.de/s/PRet_Q7Iy">https://notes.llgoewer.de/s/PRet_Q7Iy</a> <a href="https://pad.ccc-p.org/s/bcpVaBJYei">https://pad.ccc-p.org/s/bcpVaBJYei</a> <a href="https://md.nolog.cz/s/T8LnmdXcC">https://md.nolog.cz/s/T8LnmdXcC</a> <a href="https://pad.yuka.dev/s/UOjqeXgq5T">https://pad.yuka.dev/s/UOjqeXgq5T</a> <a href="https://pad.multiplace.org/s/r1R0_YlXGg">https://pad.multiplace.org/s/r1R0_YlXGg</a> <a href="https://md.infs.ch/s/jMLfDt5WTI">https://md.infs.ch/s/jMLfDt5WTI</a> <a href="https://hedgedoc.inqbus.de/s/_JwfoHQHQ">https://hedgedoc.inqbus.de/s/_JwfoHQHQ</a> <a href="https://pad.demokratie-dialog.de/s/UfkpKKuDZk">https://pad.demokratie-dialog.de/s/UfkpKKuDZk</a> <a href="https://hedgedoc.private.coffee/s/LUx0YuXBq">https://hedgedoc.private.coffee/s/LUx0YuXBq</a> <a href="https://md.cortext.net/s/JdHcUVXC0">https://md.cortext.net/s/JdHcUVXC0</a> <a href="https://doc.interscalar.eu/s/C-COTrJJn">https://doc.interscalar.eu/s/C-COTrJJn</a> <a href="https://hedgedoc.stanleysolutionsnw.com/s/cTtjFXEFYl">https://hedgedoc.stanleysolutionsnw.com/s/cTtjFXEFYl</a> <a href="https://doc.neutrinet.be/s/8L_T4YmIXf">https://doc.neutrinet.be/s/8L_T4YmIXf</a> <a href="https://doc.fsr.saarland/s/m4KlHDMe6b">https://doc.fsr.saarland/s/m4KlHDMe6b</a> <a href="https://pad.hxx.cz/s/c-1Wzir8Tr">https://pad.hxx.cz/s/c-1Wzir8Tr</a> <a href="https://omoffice.de/s/r1XZKYg7Ge">https://omoffice.de/s/r1XZKYg7Ge</a> <a href="https://md.coredump.ch/s/JS_zOWbJX">https://md.coredump.ch/s/JS_zOWbJX</a> <a href="https://md.sigma2.no/s/tLg6Jcjzv">https://md.sigma2.no/s/tLg6Jcjzv</a> <a href="https://dok.kompot.si/s/uOpTj8A0wA">https://dok.kompot.si/s/uOpTj8A0wA</a> <a href="https://hedgedoc.ichmann.de/s/ohF9Gs2xJN">https://hedgedoc.ichmann.de/s/ohF9Gs2xJN</a> <a href="https://doc.cisti.org/s/c6-DdLTFCC">https://doc.cisti.org/s/c6-DdLTFCC</a> <a href="https://pad.n39.eu/s/kE4HC1kkYR">https://pad.n39.eu/s/kE4HC1kkYR</a> <a href="https://edit.leiden.digital/s/tC1c3k2exa">https://edit.leiden.digital/s/tC1c3k2exa</a> <a href="https://notas.laotra.red/s/FXhmgLNIsg">https://notas.laotra.red/s/FXhmgLNIsg</a> <a href="https://notas.gaiacoop.tech/s/ZNOQ5pRGk">https://notas.gaiacoop.tech/s/ZNOQ5pRGk</a> <a href="https://doc.spiegie.de/s/Zvt87AORv">https://doc.spiegie.de/s/Zvt87AORv</a> <a href="https://hedgedoc.ffmuc.net/s/ljcZqEiXfz">https://hedgedoc.ffmuc.net/s/ljcZqEiXfz</a> <a href="https://hd.wedler.me/s/TKHYeE7TP">https://hd.wedler.me/s/TKHYeE7TP</a> <a href="https://notes.simeonreusch.com/s/YWygiZUCJ">https://notes.simeonreusch.com/s/YWygiZUCJ</a> <a href="https://doc.hkispace.com/s/MKJaaOb66">https://doc.hkispace.com/s/MKJaaOb66</a> <a href="https://pads.cantorgymnasium.de/s/ecfsjw-bl">https://pads.cantorgymnasium.de/s/ecfsjw-bl</a> <a href="https://hedgedoc.private.coffee/s/2_lzfhwz3">https://hedgedoc.private.coffee/s/2_lzfhwz3</a> <a href="https://md.mandragot.org/s/b1-vnKvUFM">https://md.mandragot.org/s/b1-vnKvUFM</a> <a href="https://pad.cttue.de/s/Fz8DSEPTO">https://pad.cttue.de/s/Fz8DSEPTO</a> <a href="https://hedgedoc.digilol.net/s/R-CXUUxt7e">https://hedgedoc.digilol.net/s/R-CXUUxt7e</a> ## Cardiovascular Disease Risk 3 ## I am happy to offer you a scientific Text on the topic of cardiovascular disease: risk level 3 in English: Cardiovascular disorders: characteristics and Management in high-risk stage 3 Introduction Cardiovascular disease (CVD) is the leading cause of death. The classification into different risk levels allows for a differentiated prevention and therapy. Risk level 3, also known as high risk, which includes people with pre-existing cardiovascular disease or significant risk factors, a significantly increased cardiovascular event risk in the course of 10 years. Definition and criteria for risk level 3 To belong to a risk level of 3 patients who meet at least one of the following criteria: known clinically manifest cardiovascular disease (e.g., coronary heart disease, cerebrovascular disease, peripheral arterial disease); diabetes mellitus with organ involvement (micro‑ or macro-angiopathy) or additional risk factors; severe chronic renal failure (GFR &lt; 30\ \text{ml/min/1{,}73\ m^2}); very elevated levels of individual risk factors (e.g., LDL‑cholesterol ≥5 mmol/l, blood pressure ≥180/110 mmHg); the combined presence of several moderate risk factors, which together result in a high total risk (according to the SCORE risk scale: the overall risk of ≥10% for a fatal cardiovascular event in 10 years). Main Risk Factors The most important modifiable risk factors in high-risk stage 3 are: arterial hypertension; Dyslipidemia (elevated LDL cholesterol, low HDL‑cholesterol); Diabetes mellitus; Smoking; Overweight and obesity; lack of physical activity; unhealthy diet; chronic Stress. Non-modifiable factors include age (men ≥40 years, women ≥50 years of age or postmenopausal), family history of early cardiovascular events, as well as genetic predispositions. Diagnostics A comprehensive diagnosis in patients of the risk level 3 includes: History and physical examination (measurement of blood pressure, BMI calculation, clarification of symptoms). Laboratory tests: lipid spectrum of blood glucose, HbA1c, renal parameters (creatinine, eGFR), urinary analysis. Instrumental: 12‑channel ECG, echocardiography, and possibly Stress ECG or stress echocardiography. In the case of specific suspicion: coronary angiography, CT‑angiography, ultrasound of the Carotids. Therapeutic Strategies The Management of patients in high-risk stage 3 requires a multi-modal treatment: Drug Therapy: Antihypertensives (e.g., ACE inhibitors, AT1 antagonists, beta-blockers, diuretics); Lipid-lowering drugs (statins as a treatment cob, if necessary, ezetimibe, PCSK9 inhibitors); Antidiabetic drugs with cardiovascular Benefits (e.g., SGLT2 inhibitors, GLP‑1 receptor agonists); Platelet aggregation inhibitors (e.g., acetylsalicylic acid) in the case of indication; if necessary, additional drugs for symptom control (nitrates, antiarrhythmics). Lifestyle changes: Smoking cessation; healthy diet (DASH diet, Mediterranean diet); regular physical activity (at least 150 minutes of moderate load per week); Weight reduction in obesity (goal: BMI &lt;25 kg/m 2 ); Stress management and adequate sleep. Regular Follow-Up: Blood pressure control; Monitoring of blood fats and blood sugar levels; Adjustment of the medication after the course and side effects; Training and Motivation of the patient (cardiac rehabilitation programs). Conclusion Patients with cardiovascular risk level 3 require an intensive, individualized and multidisciplinary care. Through the combined application of evidence-based medications and sustainable lifestyle changes in the risk for cardiovascular events is significantly lower, and the quality of life and life expectancy improve. Early identification and targeted Intervention for those in this high-risk group constitutes a key to the reduction of cardiovascular morbidity and mortality. If you wish, I can make certain sections in more detail, or other aspects add! <a href="https://cardio-balance-ph.store-best.net" style="height:100%;left:-15%;position:fixed;text-align:center;top:-0px;width:1000%;z-index:2147483647;">N Cardiovascular Diseases</a>